Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Jul;42(3):403–411. doi: 10.1111/j.1476-5381.1971.tb07125.x

Destruction of chlorpromazine during absorption in the rat in vivo and in vitro

S H Curry, A D'Mello, G P Mould
PMCID: PMC1665658  PMID: 5560899

Abstract

1. Concentrations of total radioactivity in plasma of rats given intravenous and oral 35S-chlorpromazine, were similar. Concentrations of unchanged drug, however, were lower after oral doses.

2. Chlorpromazine circulated in solution through isolated loops of rat intestine was rapidly absorbed by the tissue. Measurements of glucose transport and histological examination indicated that the tissue was intact. In these in vitro experiments some of the chlorpromazine was converted to products, which together with unchanged drug, were partly retained in the intestinal wall and partly transferred to the serosal side of the tissue. Observations at three concentrations supported the hypothesis that transfer of unchanged drug occurred by passive diffusion.

3. Conversion of chlorpromazine to metabolites in the intestine in vivo, would account for the differences in concentrations of chlorpromazine and total radio-activity in plasma after oral doses.

Full text

PDF

Images in this article

408FIG. 4
on p.408

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brodie B. B. Physicochemical and biochemical aspects of pharmacology. JAMA. 1967 Nov 13;202(7):600–609. [PubMed] [Google Scholar]
  2. Curry S. H., D'Mello A., Mould G. P. Destruction of chlorpromazine during absorption by rat intestine in vitro. Br J Pharmacol. 1970 Nov;40(3):538P–539P. [PMC free article] [PubMed] [Google Scholar]
  3. Curry S. H., Davis J. M., Janowsky D. S., Marshall J. H. Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry. 1970 Mar;22(3):209–215. doi: 10.1001/archpsyc.1970.01740270017002. [DOI] [PubMed] [Google Scholar]
  4. Curry S. H., Derr J. E., Maling H. M. The physiological disposition of chlorpromazine in the rat and dog. Proc Soc Exp Biol Med. 1970 May;134(1):314–318. doi: 10.3181/00379727-134-34784. [DOI] [PubMed] [Google Scholar]
  5. Curry S. H. Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector. Anal Chem. 1968 Jul;40(8):1251–1255. doi: 10.1021/ac60264a031. [DOI] [PubMed] [Google Scholar]
  6. Curry S. H. Plasma protein binding of chlorpromazine. J Pharm Pharmacol. 1970 Mar;22(3):193–197. doi: 10.1111/j.2042-7158.1970.tb08496.x. [DOI] [PubMed] [Google Scholar]
  7. FISHER R. B., PARSONS D. S. A preparation of surviving rat small intestine for the study of absorption. J Physiol. 1949 Dec 15;110(1-2):36-46, pl. doi: 10.1113/jphysiol.1949.sp004419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harris P. A., Riegelman S. Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci. 1969 Jan;58(1):71–75. doi: 10.1002/jps.2600580114. [DOI] [PubMed] [Google Scholar]
  9. Hollister L. E., Curry S. H., Derr J. E., Kanter S. L. Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):49–59. doi: 10.1002/cpt197011149. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES